Most importantly, TLR4 expression is positively associated with overall survival (hazard ratio [HR] = 0.38) and cancer-specific survival (HR = 0.15) rates in bladder cancer patients [77]. This evidence concerns the gene TLR4 and urinary bladder carcinoma.